Shareholder Votes

NU SKIN ENTERPRISES, INC. shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026 at the 2026-05-28 meeting.

“Ratification of PricewaterhouseCoopers LLP 38,798,633 970,082 65,184 0”

NU SKIN ENTERPRISES, INC. shareholders approved Approval of the Company’s Amended and Restated 2024 Omnibus Incentive Plan at the 2026-05-28 meeting.

“Approval of the Amended and Restated 2024 Omnibus Incentive Plan 24,185,333 10,177,825 40,483 5,430,258”

NU SKIN ENTERPRISES, INC. shareholders approved Advisory approval of the Company’s executive compensation at the 2026-05-28 meeting.

“Advisory Approval of the Company’s Executive Compensation 33,111,458 1,255,101 37,082 5,430,258”

NU SKIN ENTERPRISES, INC. shareholders approved Election of nine directors to serve until their successors are duly elected and qualified at the next annual meeting of stockholders or until their earlier death, resignation or removal at the 2026-05-28 meeting.

“Election of Directors Emma S. Battle 33,948,833 403,121 51,687 5,430,258 Daniel W. Campbell 33,978,430 298,746 126,465 5,430,258 Steven J. Lund 33,854,219 520,147 29,275 5,430,258 Ryan S. Napierski 34,083,028 289,928 30,685 5,430,258 Laura Nathanson 33,593,418 767,205 43,018 5,430,258 Thomas R. Pisano 34,078,549 279,972 45,120 5,430,258 James M. Winett 34,027,452 330,366 45,823 5,430,258 Edwina D. Woodbury 33,953,493 399,800 50,348 5,430,258 Mark A. Zorko 34,036,158 322,233 45,250 5,430,258”

SILGAN HOLDINGS INC shareholders approved Non-binding advisory vote to approve compensation of Named Executive Officers at the 2026-05-26 meeting.

“The non-binding advisory vote to approve the compensation of the Named Executive Officers of the Registrant received the following votes: For 96,755,314 Against 3,231,739 Abstain 20,864 Broker Non-Votes 3,077,133”

SILGAN HOLDINGS INC shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-26 meeting.

“The proposal to ratify the appointment of Ernst & Young LLP as the Registrant’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved based upon the following votes: For 102,474,220 Against 593,185 Abstain 17,645”

SILGAN HOLDINGS INC shareholders approved Approval of First Amendment to the Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan at the 2026-05-26 meeting.

“The proposal to approve the First Amendment to the Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan was approved based upon the following votes: For 99,176,056 Against 793,665 Abstain 38,196 Broker Non-Votes 3,077,133”

SILGAN HOLDINGS INC shareholders approved Election of Directors at the 2026-05-26 meeting.

“Each of the three nominees for election to the Board of Directors of the Registrant was elected as a Director of the Registrant, to serve until the Registrant’s annual meeting of stockholders in 2029 and until his or her successor is duly elected and qualified, based upon the following votes: Withhold Broker Nominee For Authority Non-Votes Leigh J. Abramson 87,358,935 12,648,982 3,077,133 Robert B. Lewis 99,604,397 403,520 3,077,133 Niharika Ramdev 98,317,120 1,690,797 3,077,133”

FiscalNote Holdings, Inc. shareholders approved Ratification of RSM US LLP as independent auditor for 2026 at the 2026-05-27 meeting.

“For Against Abstain 28,118,673 224,144 116,794”

FiscalNote Holdings, Inc. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2026-05-27 meeting.

“Every 1 Year Every 2 Years Every 3 Years Abstain Broker Non- Votes 21,450,842 190,597 26,533 69,096 6,722,543”

FiscalNote Holdings, Inc. shareholders approved Non-binding advisory vote on executive compensation at the 2026-05-27 meeting.

“For Against Abstain Broker Non- Votes 21,500,772 173,462 62,834 6,722,543”

FiscalNote Holdings, Inc. shareholders approved Election of two Class I directors: Key Compton and Timothy Hwang at the 2026-05-27 meeting.

“Name of Director Nominee For Withhold Broker Non- Votes Key Compton 21,489,942 247,126 6,722,543 Timothy Hwang 21,484,901 252,167 6,722,543”

El Pollo Loco Holdings, Inc. shareholders approved Shareholder proposal requesting the adoption of a majority voting standard for the election of directors in uncontested elections at the 2026-05-26 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 15,630,362 6,432,820 67,043 4,658,914”

El Pollo Loco Holdings, Inc. shareholders approved Approval of amendments to the El Pollo Loco Holdings, Inc. Equity Incentive Plan at the 2026-05-26 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 21,485,764 638,820 5,641 4,658,914”

El Pollo Loco Holdings, Inc. shareholders approved Non-binding advisory vote regarding the frequency of future advisory votes on named executive officers' compensation at the 2026-05-26 meeting.

““ONE YEAR” “TWO YEARS” “THREE YEARS” Abstentions 20,056,383 6,777 1,999,819 67,246”

El Pollo Loco Holdings, Inc. shareholders approved Non-binding advisory vote regarding approval of the compensation of the Company's named executive officers at the 2026-05-26 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 21,942,592 175,574 12,059 4,658,914”

El Pollo Loco Holdings, Inc. shareholders approved Ratification of appointment of BDO USA, P.C. as the independent registered public accounting firm for 2026 at the 2026-05-26 meeting.

“Votes For Votes Against Abstentions 26,723,782 54,103 11,254”

El Pollo Loco Holdings, Inc. shareholders approved Election of two Class III directors at the 2026-05-26 meeting.

“Nominee Votes For Votes Withheld Broker Non-Votes Tana Davila 22,085,229 44,996 4,658,914 Frank Garrido 22,082,786 47,439 4,658,914”

AtlasClear Holdings, Inc. shareholders approved Ratification of the appointment of Haynie & Company as independent registered public accounting firm at the 2026-05-27 meeting.

“The stockholders of the Company approved the proposal to ratify the appointment of Haynie & Company as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026. Votes For Votes Against Abstentions 56,816,612 2,292,692 196,493”

AtlasClear Holdings, Inc. shareholders approved Proposal to amend the Company's 2024 Equity Incentive Plan to increase the number of shares reserved by 15,000,000 at the 2026-05-27 meeting.

“The stockholders of the Company approved the proposal to approve an amendment to the Plan to increase the number of shares of the Company’s common stock reserved for issuance thereunder by 15,000,000. Votes For Votes Against Abstentions Broker Non-Votes 19,515,189 9,025,146 132,069 30,633,393”

AtlasClear Holdings, Inc. shareholders approved Election of six nominees for director at the 2026-05-27 meeting.

“The stockholders of the Company approved the proposal to elect each of the six directors named as nominees in the Proxy Statement, each to serve until the end of the annual general meeting of shareholders to be held in respect of the fiscal year ended June 30, 2027, or as to each, until their respective successors are elected and qualified, or their earlier death, resignation, disqualification or removal. Name Votes For Votes Withheld Broker Non-Votes John Schaible 25,729,484 2,942,920 30,633,393 Craig Ridenhour 25,725,762 2,946,642 30,633,393 Thomas Hammond 26,171,031 2,501,373 30,633,393 Sandip Patel 25,539,106 3,133,298 30,633,393 Robert Keyser 27,187,355 1,485,049 30,633,393 Steven Carlson 26,278,965 2,393,439 30,633,393”

Neumora Therapeutics, Inc. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2026-05-27 meeting.

“Proposal 4. The advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers. The results of the vote were as follows: For One Year For Two Years For Three Years Abstentions Broker Non-Votes 124,682,414 23,968 7,948,592 39,349 25,026,919”

Neumora Therapeutics, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-05-27 meeting.

“Proposal 3. The advisory vote on the compensation of the Company’s named executive officers. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 131,998,871 420,917 274,535 25,026,919”

Neumora Therapeutics, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-27 meeting.

“Proposal 2. The ratification of the selection by the audit committee of the board of directors of the Company (the “Board”) of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. The results of the vote were as follows: Votes For Votes Against Abstentions 157,623,815 53,613 43,814”

Neumora Therapeutics, Inc. shareholders approved Election of three Class III directors to hold office until the 2029 annual meeting at the 2026-05-27 meeting.

“Proposal 1. The election of three Class III directors to hold office until the 2029 annual meeting of stockholders and until their respective successor is elected and qualified or until their earlier death, resignation, disqualification or removal. The results of the vote were as follows: Nominee Votes For Votes Withheld Broker Non-Votes Paul L. Berns 126,617,746 6,076,577 25,026,919 Matthew Fust 125,242,046 7,452,277 25,026,919 David Piacquad 126,878,899 5,815,424 25,026,919”

TENET HEALTHCARE CORP shareholders approved Ratification of the selection of Deloitte & Touche LLP as independent registered public accountants at the 2026-05-27 meeting.

“3. The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2026: FOR AGAINST ABSTAIN BROKER NON-VOTES 79,422,386 470,477 29,318 —”

TENET HEALTHCARE CORP shareholders approved Advisory vote on executive compensation at the 2026-05-27 meeting.

“2. The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation: FOR AGAINST ABSTAIN BROKER NON-VOTES 62,554,346 11,817,273 39,895 5,510,667”

TENET HEALTHCARE CORP shareholders approved Election of Directors at the 2026-05-27 meeting.

“1. The Company’s shareholders elected the following directors to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Saumya Sutaria 72,297,676 2,036,933 76,905 5,510,667 J. Robert Kerrey 71,837,362 2,539,818 34,334 5,510,667 Vineeta Agarwala 73,763,259 621,321 26,934 5,510,667 James L. Bierman 73,793,459 550,313 67,742 5,510,667 Roy Blunt 73,768,660 572,299 70,555 5,510,667 Richard W. Fisher 73,759,704 583,669 68,141 5,510,667 Meghan M. FitzGerald 73,162,461 1,222,005 27,048 5,510,667 Cecil D. Haney 73,782,103 549,561 79,850 5,510,667 Christopher S. Lynch 73,771,835 570,200 69,479 5,510,667 Richard J. Mark 73,767,877 574,980 68,657 5,510,667 Tammy Romo 73,149,469 1,233,024 29,021 5,510,667 Nadja Y. West 73,659,093 710,537 41,884 5,510,667”

ACADIA PHARMACEUTICALS INC shareholders approved Approval of amendment to the Plan to increase authorized shares by 5,209,670 shares at the 2026-05-29 meeting.

“the approval of an amendment to the Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the Plan by 5,209,670 shares, which was approved by the following vote: For Against Abstain Broker Non-Votes 147,258,860 3,096,136 93,751 10,356,394”

ACADIA PHARMACEUTICALS INC shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-29 meeting.

“the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, which was ratified by the following vote: For Against Abstain 157,409,378 3,319,736 76,027”

ACADIA PHARMACEUTICALS INC shareholders approved Advisory approval of named executive officer compensation at the 2026-05-29 meeting.

“the approval, on an advisory basis, of the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement, which was approved by the following vote: For Against Abstain Broker Non-Votes 148,265,173 1,911,358 272,216 10,356,394”

ACADIA PHARMACEUTICALS INC shareholders approved Election of three Class I directors at the 2026-05-29 meeting.

“The following three Class I directors were elected by the votes indicated: For Withheld Broker Non-Votes James M. Daly 146,927,745 3,521,002 10,356,394 Edmund P. Harrigan, M.D. 128,460,130 21,988,617 10,356,394 Adora Ndu, Pharm.D., J.D. 134,540,552 15,908,195 10,356,394”

AMERICAN COASTAL INSURANCE Corp shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-12-31 meeting.

“The stockholders ratified the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2026.”

AMERICAN COASTAL INSURANCE Corp shareholders approved Election of five Class B directors for a two-year term.

“The Company's 2026 Annual Meeting was held for stockholders to consider and act upon the two proposals listed below.”

Maplebear Inc. shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2026-05-22 meeting.

“The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.”

Maplebear Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-05-22 meeting.

“The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.”

Maplebear Inc. shareholders approved Election of two Class III directors to hold office until the 2029 Annual Meeting of Stockholders at the 2026-05-22 meeting.

“The Company’s stockholders elected each of the two nominees named below as Class III directors to serve until the Company’s 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation, or removal.”

Bandwidth Inc. shareholders approved Approval, on an Advisory Basis, of the Frequency of Future Advisory Votes on the Compensation of the Company’s Named Executive Officers at the 2026-05-28 meeting.

“Proposal 4 — Approval, on an Advisory Basis, of the Frequency of Future Advisory Votes on the Compensation of the Company’s Named Executive Officers. The stockholders approved, on an advisory basis, the frequency with which future advisory votes on the compensation of the Company’s named executive officers will be held. The results of such vote were: Each Year Every Two Years Every Three Years Withheld/Abstain 39,327,229 20,323 1,526,775 60,832”

Bandwidth Inc. shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-05-28 meeting.

“Proposal 3 — Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers. The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The results of such vote were: For Against Withheld/Abstain 30,884,728 10,011,929 38,502”

Bandwidth Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-28 meeting.

“Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of such vote were: For Against Withheld/Abstain 43,322,421 153,912 19,504”

Bandwidth Inc. shareholders approved Election of Directors at the 2026-05-28 meeting.

“Proposal 1 — Election of Directors. The stockholders elected the persons named below as Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The results of such vote were: Nominee For Withheld/Abstain Broker Non-Votes David A. Morken 33,541,145 7,394,014 2,560,678 Rebecca G. Bottorff 31,861,098 9,074,061 2,560,678”

PROKIDNEY CORP. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-28 meeting.

“The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified based on the following results of the voting: For Against Abstain Broker Non Votes 239,091,167 729,165 382,882 –”

PROKIDNEY CORP. shareholders approved Election of three director nominees to serve for three-year terms at the 2026-05-28 meeting.

“Based on the following results of the voting, the Company’s stockholders elected the nominees listed below to the Company’s Board of Directors, each to serve for a three-year term to expire at the Company’s annual meeting of stockholders in 2029 and until their successors are duly elected and qualified: Director Nominee For Withhold Broker Non Votes William F. Doyle 196,164,585 1,459,235 42,579,394 Alan M. Lotvin, M.D. 193,179,768 4,444,052 42,579,394 Brian J.G. Pereira 197,002,580 621,240 42,579,394”

EXXON MOBIL CORP shareholders rejected Modify Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations at the 2026-05-27 meeting.

“Proposal 6 – Proposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board’s recommendations: Votes Cast For: 709,666,879 23.5 % Votes Cast Against: 2,304,505,127 76.5 % Abstentions: 143,045,579 Broker Non-Votes: 479,646,841”

EXXON MOBIL CORP shareholders rejected Independent Chair at the 2026-05-27 meeting.

“Proposal 5 – Independent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000: Votes Cast For: 475,238,535 15.2 % Votes Cast Against: 2,644,936,703 84.8 % Abstentions: 37,017,564 Broker Non-Votes: 479,646,841”

EXXON MOBIL CORP shareholders approved Texas Redomiciliation at the 2026-05-27 meeting.

“Proposal 4 – Texas Redomiciliation: Votes Cast For: 2,216,403,048 71.2 % Votes Cast Against: 896,852,562 28.8 % Abstentions: 30,111,060 Broker Non-Votes: 493,518,532”

EXXON MOBIL CORP shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-05-27 meeting.

“Proposal 3 – Advisory Vote to Approve Executive Compensation: Votes Cast For: 2,906,869,914 92.9 % Votes Cast Against: 222,967,504 7.1 % Abstentions: 27,391,137 Broker Non-Votes: 479,646,841”

EXXON MOBIL CORP shareholders approved Ratification of Independent Auditors at the 2026-05-27 meeting.

“Proposal 2 – Ratification of Independent Auditors: Votes Cast For: 3,493,776,585 96.4 % Votes Cast Against: 130,902,587 3.6 % Abstentions: 12,204,753 Broker Non-Votes: 0”

EXXON MOBIL CORP shareholders approved Election of Directors at the 2026-05-27 meeting.

“Proposal 1 – Election of Directors The shareholders elected each of the Board’s twelve director nominees.”

BENCHMARK ELECTRONICS INC shareholders approved Amendment to 2019 Omnibus Incentive Compensation Plan at the 2026-05-28 meeting.

“4) The proposal to amend the 2019 Omnibus Incentive Compensation Plan was approved based on the following votes: For Against Abstain Non-Vote 31,499,913 884,076 115,072 1,332,273”